Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 16/20 | 0.67 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.67 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.67 |
| ▸ | DRD2 | P14416 | 2/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.67 |
| ▸ | PGR | P06401 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | DRD3 | P35462 | 1/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salmefamol SCHEMBL20285629 | 1.00 | ADRB2 (0.67) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| Salmefamol SCHEMBL18458 | 1.00 | ADRB2 (0.67) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL11180299 | 0.90 | ADRB2 (0.69) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| Arformoterol SCHEMBL5849657 | 0.89 | ADRB2 (0.87) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL4255154 | 0.89 | ADRB2 (0.71) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL4255159 | 0.89 | ADRB2 (0.71) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL11174404 | 0.89 | ADRB2 (0.61) | ADRB2ADRB1ADRB3SLC6A4ADRA1A | |
| Salmefamol SCHEMBL2221384 | 0.89 | ADRB2 (0.68) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL11180151 | 0.89 | ADRB2 (0.56) | ADRB2ADRB1ADRB3DRD2SLC6A4 | |
| SCHEMBL11810215 | 0.88 | ADRB2 (0.73) | ADRB2ADRB1ADRB3DRD2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090869-A1 | SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF | 3I BIOTECH LLC (US) | 2026-04-02 | — | — | US | disclosed |
| CN-115989019-A | Forms and compositions of beta adrenergic agonists | 库拉森疗法公司 | 2023-04-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090869-A1 | SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF | MALT1, CDH1, VEGFA | ADRB2 1565/4885ADRB1 1432/4885ADRB3 1136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.